Xian Ping Lu
Chief Executive Officer at SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
Net worth: 67 M $ as of 2024-04-29
Xian Ping Lu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Chief Executive Officer | 2018-03-23 | - |
| Chairman | 2018-03-23 | - | |
| Founder | 2001-03-20 | - | |
| Director/Board Member | 2001-03-20 | 2018-03-23 | |
| Chief Tech/Sci/R&D Officer | 2001-03-20 | 2019-12-31 | |
| President | 2001-03-20 | 2018-03-23 |
Career history of Xian Ping Lu
Former positions of Xian Ping Lu
| Companies | Position | Start | End |
|---|---|---|---|
Galderma Research & Development SNC
 Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Corporate Officer/Principal | - | - |
Maxia Pharmaceuticals, Inc.
 Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Founder | - | - |
Training of Xian Ping Lu
| Sichuan University | Undergraduate Degree |
| Peking Union Medical College | Graduate Degree |
Statistics
International
| China | 4 |
| United States | 2 |
| France | 2 |
Operational
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Maxia Pharmaceuticals, Inc.
Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Commercial Services |
Galderma Research & Development SNC
Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Health Technology |
- Stock Market
- Insiders
- Xian Ping Lu
- Experience
